
Jonathan S. Lau
Examiner (ID: 8893, Phone: (571)270-3531 , Office: P/1673 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1693, 1623, 1673 |
| Total Applications | 1249 |
| Issued Applications | 700 |
| Pending Applications | 107 |
| Abandoned Applications | 463 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15290399
[patent_doc_number] => 20190388335
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => INJECTABLE FORMULATIONS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/433259
[patent_app_country] => US
[patent_app_date] => 2019-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19042
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16433259
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/433259 | INJECTABLE FORMULATIONS FOR TREATING CANCER | Jun 5, 2019 | Abandoned |
Array
(
[id] => 17680973
[patent_doc_number] => 11365212
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-06-21
[patent_title] => Fluorinated N-acetyl glucosamine analogs and xylose derivatives
[patent_app_type] => utility
[patent_app_number] => 17/059318
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 21
[patent_no_of_words] => 27674
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17059318
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/059318 | Fluorinated N-acetyl glucosamine analogs and xylose derivatives | May 30, 2019 | Issued |
Array
(
[id] => 14864711
[patent_doc_number] => 20190282597
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-19
[patent_title] => SYNTHETIC DISUGAR HYDROCARBONS AS NATURAL ANALOGS TO CONTROL MICROBIAL BEHAVIORS
[patent_app_type] => utility
[patent_app_number] => 16/423543
[patent_app_country] => US
[patent_app_date] => 2019-05-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21924
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16423543
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/423543 | SYNTHETIC DISUGAR HYDROCARBONS AS NATURAL ANALOGS TO CONTROL MICROBIAL BEHAVIORS | May 27, 2019 | Abandoned |
Array
(
[id] => 16991893
[patent_doc_number] => 20210230313
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-29
[patent_title] => SULFUR-CONTAINING GLYCANS AND POLYSACCHARIDES AND METHODS OF CHEMOENZYMATIC SYNTHESIS THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/734499
[patent_app_country] => US
[patent_app_date] => 2019-05-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10667
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15734499
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/734499 | SULFUR-CONTAINING GLYCANS AND POLYSACCHARIDES AND METHODS OF CHEMOENZYMATIC SYNTHESIS THEREOF | May 23, 2019 | Abandoned |
Array
(
[id] => 16963011
[patent_doc_number] => 20210214510
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => NANOFIBRILLAR CELLULOSE HYDROGEL
[patent_app_type] => utility
[patent_app_number] => 17/056829
[patent_app_country] => US
[patent_app_date] => 2019-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13695
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17056829
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/056829 | NANOFIBRILLAR CELLULOSE HYDROGEL | May 22, 2019 | Abandoned |
Array
(
[id] => 16930853
[patent_doc_number] => 20210196742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-01
[patent_title] => AMINO ACID SALTS OF NICOTINIC ACID RIBOSIDES AS ANTI-AGING AGENTS
[patent_app_type] => utility
[patent_app_number] => 17/057380
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11144
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -41
[patent_words_short_claim] => 112
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17057380
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/057380 | Amino acid salts of nicotinic acid ribosides as anti-aging agents | May 21, 2019 | Issued |
Array
(
[id] => 14833329
[patent_doc_number] => 20190275065
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => METHOD FOR IMPROVING VENTILATORY EFFICIENCY
[patent_app_type] => utility
[patent_app_number] => 16/419134
[patent_app_country] => US
[patent_app_date] => 2019-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2607
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16419134
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/419134 | METHOD FOR IMPROVING VENTILATORY EFFICIENCY | May 21, 2019 | Abandoned |
Array
(
[id] => 17065790
[patent_doc_number] => 20210268005
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-02
[patent_title] => COMPOSITION COMPRISING HUMAN MILK OLIGOSACCHARIDES FOR USE IN IMPROVING, ENHANCING, PROMOTING OR MODULATING A GABAERGIC FUNCTION IN THE CENTRAL NERVOUS SYSTEM
[patent_app_type] => utility
[patent_app_number] => 17/255013
[patent_app_country] => US
[patent_app_date] => 2019-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11126
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17255013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/255013 | Composition comprising human milk oligosaccharides for use in improving, enhancing, promoting or modulating a gabaergic function in the central nervous system | May 20, 2019 | Issued |
Array
(
[id] => 16913905
[patent_doc_number] => 20210186997
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => METHODS AND COMPOSITIONS FOR INCREASING NAD LEVEL IN MAMMALS WITH D-RIBOSE AND VITAMIN B3
[patent_app_type] => utility
[patent_app_number] => 17/054512
[patent_app_country] => US
[patent_app_date] => 2019-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3378
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17054512
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/054512 | METHODS AND COMPOSITIONS FOR INCREASING NAD LEVEL IN MAMMALS WITH D-RIBOSE AND VITAMIN B3 | May 9, 2019 | Abandoned |
Array
(
[id] => 17822713
[patent_doc_number] => 11427651
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-30
[patent_title] => Process for the preparation of essential oils modified nanocellulose and application thereof
[patent_app_type] => utility
[patent_app_number] => 17/052187
[patent_app_country] => US
[patent_app_date] => 2019-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 5265
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 482
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052187
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/052187 | Process for the preparation of essential oils modified nanocellulose and application thereof | May 1, 2019 | Issued |
Array
(
[id] => 15678535
[patent_doc_number] => 20200093931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-03-26
[patent_title] => COMPOUNDS FOR TREATING BIOFILM INFECTION
[patent_app_type] => utility
[patent_app_number] => 16/398939
[patent_app_country] => US
[patent_app_date] => 2019-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9736
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16398939
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/398939 | Compounds for treating biofilm infection | Apr 29, 2019 | Issued |
Array
(
[id] => 17112145
[patent_doc_number] => 20210292742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-09-23
[patent_title] => METHOD FOR ISOLATING NUCLEIC ACIDS FROM PLANT SAMPLES
[patent_app_type] => utility
[patent_app_number] => 17/048788
[patent_app_country] => US
[patent_app_date] => 2019-04-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26008
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17048788
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/048788 | Method for isolating nucleic acids from plant samples | Apr 28, 2019 | Issued |
Array
(
[id] => 15144963
[patent_doc_number] => 20190350959
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-21
[patent_title] => INJECTABLE FORMULATIONS FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 16/396017
[patent_app_country] => US
[patent_app_date] => 2019-04-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17001
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396017
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/396017 | INJECTABLE FORMULATIONS FOR TREATING CANCER | Apr 25, 2019 | Abandoned |
Array
(
[id] => 17149479
[patent_doc_number] => 11142542
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-12
[patent_title] => Method for synthesizing sucrose-6-ester
[patent_app_type] => utility
[patent_app_number] => 16/981986
[patent_app_country] => US
[patent_app_date] => 2019-04-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5737
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16981986
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/981986 | Method for synthesizing sucrose-6-ester | Apr 23, 2019 | Issued |
Array
(
[id] => 17769369
[patent_doc_number] => 11401296
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-08-02
[patent_title] => Amidite compound and method for producing polynucleotide using said compound
[patent_app_type] => utility
[patent_app_number] => 17/049905
[patent_app_country] => US
[patent_app_date] => 2019-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10899
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 73
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049905
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/049905 | Amidite compound and method for producing polynucleotide using said compound | Apr 22, 2019 | Issued |
Array
(
[id] => 17896911
[patent_doc_number] => 20220306573
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-29
[patent_title] => OLIGONUCLEOTIDE COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/046752
[patent_app_country] => US
[patent_app_date] => 2019-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 252427
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -43
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17046752
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/046752 | Oligonucleotide compositions and methods of use thereof | Apr 10, 2019 | Issued |
Array
(
[id] => 17133700
[patent_doc_number] => 11135236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-10-05
[patent_title] => Retinoic acid receptor gamma agonists to attenuate anthracycline-induced cardiotoxicity
[patent_app_type] => utility
[patent_app_number] => 16/376392
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 11
[patent_no_of_words] => 16382
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376392
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/376392 | Retinoic acid receptor gamma agonists to attenuate anthracycline-induced cardiotoxicity | Apr 4, 2019 | Issued |
Array
(
[id] => 16025789
[patent_doc_number] => 10675294
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-09
[patent_title] => Pharmaceutical composition containing 8 OXO-deoxyguanosine or pharmaceutically acceptable salt thereof as active ingredient for treating corneal disease
[patent_app_type] => utility
[patent_app_number] => 16/376140
[patent_app_country] => US
[patent_app_date] => 2019-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 6042
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376140
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/376140 | Pharmaceutical composition containing 8 OXO-deoxyguanosine or pharmaceutically acceptable salt thereof as active ingredient for treating corneal disease | Apr 4, 2019 | Issued |
Array
(
[id] => 16612126
[patent_doc_number] => 20210030779
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-02-04
[patent_title] => COMBINATION OF A CANNABINOID AND A CHEMOTHERAOPEUTIC AGENT FOR THE TREATMENT OF BREAST CANCER
[patent_app_type] => utility
[patent_app_number] => 17/044534
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4365
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044534
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044534 | Combination of a cannabinoid and a chemotheraopeutic agent for the treatment of breast cancer | Apr 3, 2019 | Issued |
Array
(
[id] => 16854906
[patent_doc_number] => 20210155651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-27
[patent_title] => PROCESS FOR THE PREPARATION OF IRON (III) CARBOXYMALTOSE
[patent_app_type] => utility
[patent_app_number] => 17/044310
[patent_app_country] => US
[patent_app_date] => 2019-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4424
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17044310
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/044310 | PROCESS FOR THE PREPARATION OF IRON (III) CARBOXYMALTOSE | Apr 3, 2019 | Abandoned |